Guerbet Targets Multi-Use Markets To Grow Diagnostic Imaging Biz

French imaging agent specialist Guerbet is targeting multi-use markets to grow its diagnostic imaging business while continuing to build through acquisitions. While its diagnostic imaging revenues were about flat in 2018, its imaging intervention business grew almost 19% in constant currency compared to 2017.

in CT laboratory. Observation room in an office with a computer tomograph

Guerbet SA is focusing on strengthening its interventional imaging offerings following a dip in revenue in 2018.

The company recently launched a new multi-use OptiVantage injector for injecting contrast agents into a patient’s vascular system during CT examinations

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Diagnostic Imaging

More from Diagnostics